SEC Form 8-K Summary
Filing identification: The provided filing is for Brilliant Acquisition Corporation, not T3 Defense Inc. The report concerns a shareholder vote held on December 13, 2023 and was signed on December 19, 2023.
Business Context and Reporting Period
Brilliant is a British Virgin Islands special purpose acquisition company. It reported shareholder approval of its proposed business combination with Nukkleus Inc. Under the transaction, Brilliant would re-domicile to Delaware, and a merger subsidiary would merge with Nukkleus, with Nukkleus surviving as a wholly owned subsidiary.
There were 1,814,696 shares entitled to vote. Holders of 1,362,515 shares voted, representing 75.08% of outstanding shares.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, cash, trust-account balance, redemption amounts, or other detailed financial metrics. It notes that completion remains subject to, among other conditions, satisfaction of a minimum trust-account amount after public-shareholder redemptions.
Material Changes and Shareholder Vote Results
| Proposal | For | Against | Abstain |
|---|---|---|---|
| Business combination | 1,359,686 | 2,829 | 0 |
| Domestication to Delaware | 1,359,686 | 2,829 | 0 |
| Amended and restated charter | 1,359,686 | 2,829 | 0 |
| Advisory proposals 4A–4D | 1,359,681–1,359,686 | 2,829–2,830 | 0–5 |
| 2023 equity incentive plan | 1,356,234 | 6,281 | 0 |
| Nasdaq issuance and change-in-control proposal | 1,359,685 | 2,830 | 0 |
All proposals were approved. The approved charter changes include changing the corporate name to “Nukkleus, Inc.,” authorizing 40 million shares of common stock and 15 million shares of preferred stock, and removing provisions applicable only to blank-check companies.
Outlook, Risks, and Unusual Items
Brilliant stated that it expected to close the business combination in the coming days. The statement is forward-looking and does not guarantee completion.
- The transaction may not close on time or at all.
- Completion depends on satisfying closing conditions, including minimum trust-account requirements after redemptions and certain governmental or regulatory approvals.
- The transaction could affect business relationships, employee retention, operating plans, and the ability to maintain Nasdaq listing.
- Potential litigation, market volatility, regulatory changes, competition, and changes in the combined capital structure could materially affect results.
- Management cautioned that the listed risks are not exhaustive and directed investors to the applicable proxy statement, registration statement, periodic reports, and risk factors.
Important Facts to Verify
- Confirm the filing entity and transaction status, because the source filing is for Brilliant Acquisition Corporation rather than T3 Defense Inc.
- Verify whether the business combination actually closed and the date on which the domestication and merger became effective.
- Verify shareholder redemption levels and the post-redemption trust-account balance.
- Review the final ownership, capitalization, share issuance, warrants, and Nasdaq listing arrangements.
- Review Nukkleus’s latest financial statements and the transaction-specific risk factors before assessing valuation or liquidity.